Current research into semaglutide are demonstrating significant applications beyond the original indication for type 2 condition. Experts are closely examining how this GLP-1 receptor agonist affects metabolic health, cardiovascular function, and even neurological well-being. The data indicate a broad range of future treatments, inspiring more expl